{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T23:25:32Z","timestamp":1715988332781},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2010,7,6]],"date-time":"2010-07-06T00:00:00Z","timestamp":1278374400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1007\/s00262-010-0890-5","type":"journal-article","created":{"date-parts":[[2010,7,5]],"date-time":"2010-07-05T04:35:02Z","timestamp":1278304502000},"page":"1645-1653","source":"Crossref","is-referenced-by-count":12,"title":["Leukemic cell products down-regulate human dendritic cell differentiation"],"prefix":"10.1007","volume":"59","author":[{"given":"Juliana Maria","family":"Motta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clarissa Rodrigues","family":"Nascimento","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivian Mary","family":"Rumjanek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,7,6]]},"reference":[{"key":"890_CR1","first-page":"175","volume":"20","author":"JJ Biemer","year":"1990","unstructured":"Biemer JJ (1990) Malignant lymphomas associated with immunodeficiency states. Ann Clin Lab Sci 20:175\u2013191","journal-title":"Ann Clin Lab Sci"},{"key":"890_CR2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrc1252","volume":"4","author":"G Dranoff","year":"2004","unstructured":"Dranoff G (2004) Cytokines in cancer pathogenesis and cancer therapy. Nat Rev Cancer 4:11\u201322","journal-title":"Nat Rev Cancer"},{"key":"890_CR3","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3816\/CCC.2004.n.008","volume":"4","author":"L Shunyakov","year":"2004","unstructured":"Shunyakov L, Ryan CK, Sahasrabudhe DM, Khorana AA (2004) The influence of host response on colorectal cancer prognosis. Clin Colorectal Cancer 4:38\u201345","journal-title":"Clin Colorectal Cancer"},{"key":"890_CR4","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0248-8663(99)80107-6","volume":"20","author":"RT Costello","year":"1999","unstructured":"Costello RT, Gastaut JA, Olive D (1999) Mechanisms of tumor escape from immunologic response. Rev Med Interne 20:579\u2013588","journal-title":"Rev Med Interne"},{"key":"890_CR5","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1007\/s00262-004-0517-9","volume":"53","author":"I Algarra","year":"2004","unstructured":"Algarra I, Garc\u00eda-Lora A, Cabrera T, Ruiz-Cabello F, Garrido F (2004) The selection of tumor variants with altered expression of classical and nonclassical MHC class I molecules: implications for tumor immune escape. Cancer Immunol Immunother 53:904\u2013910","journal-title":"Cancer Immunol Immunother"},{"key":"890_CR6","first-page":"65","volume":"11","author":"M Shurin","year":"2001","unstructured":"Shurin M, Gabrilovich D (2001) Regulation of the dendritic cell system by tumor. Cancer Res Ther Control 11:65\u201378","journal-title":"Cancer Res Ther Control"},{"key":"890_CR7","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nrc1586","volume":"5","author":"W Zou","year":"2005","unstructured":"Zou W (2005) Immunosuppressive networks in the tumour environment and their therapeutic relevance. Nat Rev Cancer 5:263\u2013274","journal-title":"Nat Rev Cancer"},{"key":"890_CR8","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/jlb.64.3.275","volume":"64","author":"KD Elgert","year":"1998","unstructured":"Elgert KD, Alleva DG, Mullins DW (1998) Tumor-induced immune dysfunction: the macrophage connection. J Leukoc Biol 64:275\u2013290","journal-title":"J Leukoc Biol"},{"key":"890_CR9","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/82763","volume":"1","author":"P Chomarat","year":"2000","unstructured":"Chomarat P, Banchereau J, Davoust J, Palucka AK (2000) IL-6 switches the differentiation of monocytes from dendritic cells to macrophages. Nat Immunol 1:510\u2013514","journal-title":"Nat Immunol"},{"key":"890_CR10","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/(SICI)1521-4141(199801)28:01<359::AID-IMMU359>3.0.CO;2-4","volume":"28","author":"P Allavena","year":"1998","unstructured":"Allavena P, Piemonti L, Longoni D, Bernasconi S, Stoppacciaro A, Ruco L, Mantovani A (1998) IL-10 prevents the differentiation of monocytes to dendritic cells but promotes their maturation to macrophages. Eur J Immunol 28:359\u2013369","journal-title":"Eur J Immunol"},{"key":"890_CR11","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.4049\/jimmunol.161.6.2804","volume":"161","author":"P Kalinski","year":"1998","unstructured":"Kalinski P, Schuitemaker JH, Hilkens CM, Kapsenberg ML (1998) Prostaglandin E2 induces the final maturation of IL-12-deficient CD1a+CD83+ dendritic cells: the levels of IL-12 are determined during the final dendritic cell maturation and are resistant to further modulation. J Immunol 161:2804\u20132809","journal-title":"J Immunol"},{"key":"890_CR12","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/32588","volume":"392","author":"J Banchereau","year":"1998","unstructured":"Banchereau J, Steinman RM (1998) Dendritic cells and the control of immunity. Nature 392:245\u2013252","journal-title":"Nature"},{"key":"890_CR13","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1084\/jem.180.1.83","volume":"180","author":"N Romani","year":"1994","unstructured":"Romani N, Gruner S, Brang D, K\u00e4mpgen E, Lenz A, Trockenbacher B, Konwalinka G, Fritsch PO, Steinman RM, Schuler G (1994) Proliferating dendritic cell progenitors in human blood. J Exp Med 180:83\u201393","journal-title":"J Exp Med"},{"key":"890_CR14","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0167-5699(96)80544-5","volume":"17","author":"JH Peters","year":"1996","unstructured":"Peters JH, Gieseler R, Thiele B, Steinbach F (1996) Dendritic cells: from ontogenetic orphans to myelomonocytic descendants. Immunol Today 17:273\u2013278","journal-title":"Immunol Today"},{"key":"890_CR15","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0022-1759(96)00078-6","volume":"196","author":"N Romani","year":"1996","unstructured":"Romani N, Reider D, Heuer M, Ebner S, K\u00e4mpgen E, Eibl B, Niederwieser D, Schuler G (1996) Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability. J Immunol Methods 196:137\u2013151","journal-title":"J Immunol Methods"},{"key":"890_CR16","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1097\/01.ju.0000091264.46134.b7","volume":"170","author":"M Aalamian","year":"2003","unstructured":"Aalamian M, Tourkova IL, Chatta GS, Lilja H, Huland E, Huland H, Shurin GV, Shurin MR (2003) Inhibition of dendropoiesis by tumor derived and purified prostate specific antigen. J Urol 170:2026\u20132030","journal-title":"J Urol"},{"key":"890_CR17","first-page":"363","volume":"61","author":"GV Shurin","year":"2001","unstructured":"Shurin GV, Shurin MR, Bykovskaia S, Shogan J, Lotze MT, Barksdale EM Jr (2001) Neuroblastoma-derived gangliosides inhibit dendritic cell generation and function. Cancer Res 61:363\u2013369","journal-title":"Cancer Res"},{"key":"890_CR18","doi-asserted-by":"crossref","first-page":"4778","DOI":"10.1182\/blood.V92.12.4778","volume":"92","author":"C Menetrier-Caux","year":"1998","unstructured":"Menetrier-Caux C, Montmain G, Dieu MC, Bain C, Favrot MC, Caux C, Blay JY (1998) Inhibition of the differentiation of dendritic cells from CD34(+) progenitors by tumor cells: role of interleukin-6 and macrophage colony-stimulating factor. Blood 92:4778\u20134791","journal-title":"Blood"},{"key":"890_CR19","doi-asserted-by":"crossref","first-page":"5479","DOI":"10.1158\/0008-5472.CAN-06-3963","volume":"67","author":"U Bharadwaj","year":"2007","unstructured":"Bharadwaj U, Li M, Zhang R, Chen C, Yao Q (2007) Elevated interleukin-6 and G-CSF in human pancreatic cancer cell conditioned medium suppress dendritic cell differentiation and activation. Cancer Res 67:5479\u20135488","journal-title":"Cancer Res"},{"key":"890_CR20","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1172\/JCI31537","volume":"117","author":"WW Lin","year":"2007","unstructured":"Lin WW, Karin M (2007) A cytokine-mediated link between innate immunity, inflammation, and cancer. J Clin Invest 117:1175\u20131183","journal-title":"J Clin Invest"},{"key":"890_CR21","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s10555-006-9004-4","volume":"25","author":"RN Apte","year":"2006","unstructured":"Apte RN, Dotan S, Elkabets M, White MR, Reich E, Carmi Y, Song X, Dvozkin T, Krelin Y, Voronov E (2006) The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor-host interactions. Cancer Metastasis Rev 25:387\u2013408","journal-title":"Cancer Metastasis Rev"},{"key":"890_CR22","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1073\/pnas.93.6.2588","volume":"93","author":"LJ Zhou","year":"1996","unstructured":"Zhou LJ, Tedder TF (1996) CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells. Proc Natl Acad Sci USA 93:2588\u20132592","journal-title":"Proc Natl Acad Sci USA"},{"key":"890_CR23","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.cytogfr.2007.10.004","volume":"19","author":"P Blanco","year":"2008","unstructured":"Blanco P, Palucka AK, Pascual V, Banchereau J (2008) Dendritic cells and cytokines in human inflammatory and autoimmune diseases. Cytokine Growth Factor Rev 19:41\u201352","journal-title":"Cytokine Growth Factor Rev"},{"key":"890_CR24","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1084\/jem.179.4.1109","volume":"179","author":"F Sallusto","year":"1994","unstructured":"Sallusto F, Lanzavecchia A (1994) Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte\/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 179:1109\u20131118","journal-title":"J Exp Med"},{"key":"890_CR25","doi-asserted-by":"crossref","first-page":"4333","DOI":"10.4049\/jimmunol.168.9.4333","volume":"168","author":"CC Sombroek","year":"2002","unstructured":"Sombroek CC, Stam AG, Masterson AJ, Lougheed SM, Schakel MJ, Meijer CJ, Pinedo HM, van den Eertwegh AJ, Scheper RJ, de Gruijl TD (2002) Prostanoids play a major role in the primary tumor-induced inhibition of dendritic cell differentiation. J Immunol 168:4333\u20134343","journal-title":"J Immunol"},{"key":"890_CR26","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.4049\/jimmunol.164.3.1269","volume":"164","author":"SM Kiertscher","year":"2000","unstructured":"Kiertscher SM, Luo J, Dubinett SM, Roth MD (2000) Tumors promote altered maturation and early apoptosis of monocyte-derived dendritic cells. J Immunol 164:1269\u20131276","journal-title":"J Immunol"},{"key":"890_CR27","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/ijc.10576","volume":"101","author":"MR Shurin","year":"2002","unstructured":"Shurin MR, Yurkovetsky ZR, Tourkova IL, Balkir L, Shurin GV (2002) Inhibition of CD40 expression and CD40-mediated dendritic cell function by tumor-derived IL-10. Int J Cancer 101:61\u201368","journal-title":"Int J Cancer"},{"key":"890_CR28","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1182\/blood.V45.3.321.321","volume":"45","author":"CB Lozzio","year":"1975","unstructured":"Lozzio CB, Lozzio BB (1975) Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. Blood 45:321\u2013334","journal-title":"Blood"},{"key":"890_CR29","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1182\/blood.V54.3.713.713","volume":"54","author":"R Gallagher","year":"1979","unstructured":"Gallagher R, Collins S, Trujillo J, Mccredie K, Ahearn M, Tsai S, Metzgar R, Aulakh G, Ting R, Ruscetti F, Gallo R (1979) Characterization of the continuous, differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia. Blood 54:713\u2013733","journal-title":"Blood"},{"key":"890_CR30","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1099\/0022-1317-28-2-207","volume":"28","author":"A Adams","year":"1975","unstructured":"Adams A, Strander H, Cantell K (1975) Sensitivity of the Epstein\u2013Barr virus transformed human lymphoid cell lines to interferon. J Gen Virol 28:207\u2013217","journal-title":"J Gen Virol"},{"key":"890_CR31","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.4049\/jimmunol.174.5.3015","volume":"174","author":"CA Ogden","year":"2005","unstructured":"Ogden CA, Pound JD, Batth BK, Owens S, Johannessen I, Wood K, Gregory CD (2005) Enhanced apoptotic cell clearance capacity and B cell survival factor production by IL-10-activated macrophages: implications for Burkitt\u2019s lymphoma. J Immunol 174:3015\u20133023","journal-title":"J Immunol"},{"key":"890_CR32","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/sj.bjc.6690150","volume":"79","author":"EE Hillenbrand","year":"1999","unstructured":"Hillenbrand EE, Neville AM, Coventry BJ (1999) Immunohistochemical localization of CD1a-positive putative dendritic cells in human breast tumours. Br J Cancer 79:940\u2013944","journal-title":"Br J Cancer"},{"key":"890_CR33","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/ijc.10656","volume":"102","author":"HG Joo","year":"2002","unstructured":"Joo HG, Fleming TP, Tanaka Y, Dunn TJ, Linehan DC, Goedegebuure PS, Eberlein TJ (2002) Human dendritic cells induce tumor-specific apoptosis by soluble factors. Int J Cancer 102:20\u201328","journal-title":"Int J Cancer"},{"key":"890_CR34","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/nm1096-1096","volume":"2","author":"DI Gabrilovich","year":"1996","unstructured":"Gabrilovich DI, Chen HL, Girgis KR, Cunningham HT, Meny GM, Nadaf S, Kavanaugh D, Carbone DP (1996) Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells. Nat Med 2:1096\u20131103","journal-title":"Nat Med"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-010-0890-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00262-010-0890-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-010-0890-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T22:35:30Z","timestamp":1685658930000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00262-010-0890-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7,6]]},"references-count":34,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["890"],"URL":"https:\/\/doi.org\/10.1007\/s00262-010-0890-5","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,7,6]]}}}